Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 4Sarcoma 3Stomach Neoplasms 1Skin Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Liposarcoma 1Hodgkin Disease 1HIV Infections 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Castleman Disease 1AIDS-related Kaposi sarcoma 1AIDS-Related Opportunistic Infections 1

Interventions

liposomal doxorubicin 3Paclitaxel 3Thalidomide 2Semaxinib 2Polymerase Chain Reaction 2Filgrastim 2Etoposide 2Docetaxel 2Daunorubicin 2valspodar 1nirogacestat 1halofuginone 1etoposide phosphate 1entinostat 1emvododstat 1efineptakin alfa 1Valproic Acid 1Sunitinib 1Sirolimus 1Saquinavir 1SUB1 protein, human 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Palliative Care 1Nutritional Support 1Nelfinavir 1N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3- dimethyl-L-Valinamide 1Lenalidomide 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-related Kaposi sarcoma × Nelfinavir × Sarcoma × Clear all
NCT00003008 2023-06-15

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Eastern Cooperative Oncology Group

Phase 2 Completed
33 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡